calendar
23,872 catalysts · 5,000 device 510k · 4,728 grant · 4,273 approval · 3,080 8k filing · 2,000 device pma · 2,000 device recall
next 91 dayslessmore
MonWedFri
23,872 catalysts · 5,000 device 510k · 4,728 grant · 4,273 approval · 3,080 8k filing · 2,000 device pma · 2,000 device recall
Sponsor: AUROBINDO PHARMA. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL
Sponsor: GRAVITI PHARMS. Form: TABLET. Route: ORAL
Sponsor: AMNEAL PHARMS NY. Form: TABLET. Route: ORAL
Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL
Sponsor: AMNEAL PHARMS NY. Form: TABLET. Route: ORAL
Sponsor: LGM PHARMA. Form: CAPSULE. Route: ORAL
Sponsor: JANSSEN BIOTECH. Form: INJECTABLE. Route: INJECTION
Sponsor: AMNEAL PHARMS NY. Form: TABLET. Route: ORAL
Sponsor: REGCON HOLDINGS. Form: TABLET. Route: ORAL
Sponsor: REGCON HOLDINGS. Form: TABLET. Route: ORAL
Sponsor: VIVUS LLC. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL
Sponsor: AMNEAL PHARMS NY. Form: TABLET. Route: ORAL
Sponsor: ORGANON USA LLC. Form: INJECTABLE. Route: SUBCUTANEOUS
Sponsor: ALEMBIC. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL
Sponsor: ALEMBIC. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL
Sponsor: ALEMBIC. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL
Sponsor: ALEMBIC. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL
Sponsor: ALEMBIC. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL
Sponsor: ALEMBIC. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL
Sponsor: ALEMBIC. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL
Sponsor: ALEMBIC. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL
Sponsor: ALEMBIC. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL
Sponsor: ACTELION. Form: TABLET. Route: ORAL
Sponsor: ACTELION. Form: TABLET, FOR SUSPENSION. Route: ORAL
Sponsor: PAI HOLDINGS. Form: SOLUTION. Route: ORAL
Sponsor: PAI HOLDINGS. Form: SOLUTION. Route: ORAL
Sponsor: AMGEN. Form: INJECTABLE. Route: INJECTION
Sponsor: ALEXION PHARM. Form: INJECTABLE. Route: INJECTION
Sponsor: LGM PHARMA. Form: CAPSULE. Route: ORAL
Sponsor: LGM PHARMA. Form: CAPSULE. Route: ORAL
Sponsor: LGM PHARMA. Form: CAPSULE. Route: ORAL
Sponsor: YICHANG HUMANWELL. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: NOVEL LABS INC. Form: FOR SUSPENSION. Route: ORAL
Sponsor: NOVEL LABS INC. Form: FOR SUSPENSION. Route: ORAL
Sponsor: NOVEL LABS INC. Form: FOR SUSPENSION. Route: ORAL
Sponsor: NOVEL LABS INC. Form: FOR SUSPENSION. Route: ORAL
Sponsor: NOVEL LABS INC. Form: FOR SUSPENSION. Route: ORAL
Sponsor: ASPEN. Form: TABLET. Route: ORAL
Sponsor: ACERTIS PHARMS. Form: CAPSULE. Route: ORAL
Sponsor: MAYNE PHARMA. Form: CAPSULE. Route: ORAL
Sponsor: PFIZER. Form: INSERT, EXTENDED RELEASE. Route: VAGINAL
Sponsor: VERTICAL PHARMS. Form: GEL. Route: TRANSDERMAL
Sponsor: ASPEN. Form: TABLET. Route: ORAL
Sponsor: DAIICHI SANKYO. Form: INJECTABLE. Route: INJECTION
Sponsor: DR REDDYS LABS SA. Form: SOLUTION/DROPS. Route: OPHTHALMIC
Sponsor: UPSHER SMITH LABS. Form: CAPSULE. Route: ORAL
Sponsor: UPSHER SMITH LABS. Form: CAPSULE. Route: ORAL
Sponsor: EPIC PHARMA LLC. Form: TABLET. Route: ORAL
Sponsor: JANSSEN BIOTECH. Form: INJECTABLE. Route: INJECTION
Sponsor: RISING. Form: CAPSULE. Route: ORAL